Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma L Lane

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Experimental Neurology|December 17, 2013
The effect of additional noradrenergic and serotonergic depletion on a lateralised choice reaction time task in rats with nigral 6-OHDA lesionsHanna S Lindgren, Merve Demirbugen, Filip Bergqvist, et al.
Brain Research Bulletin|December 17, 2008
Genetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA modelChristelle Monville, Eduardo M Torres, Vladimir Pekarik, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 8, 2021
Factors affecting the choice of first-line therapy in Parkinson's disease patients in Wales: A population-based studyKhalid Orayj, Ashley Akbari, Arron Lacey, et al.
Behavioural Brain Research|December 8, 2011
Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sitesAndreas Heuer, Gaynor A Smith, Mariah J Lelos, et al.
Brain, Behavior, and Immunity|November 20, 2016
Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's diseaseLudivine S Breger, Korbinian Kienle, Gaynor A Smith, et al.
Scientific Reports|October 17, 2023
Impaired cognitive and motor function are coincident with L-DOPA-induced dyskinesia in a model of Parkinson's diseaseMariah J Lelos, Ellen M Murphy, Hanna S Lindgren, et al.
Neuroreport|October 23, 2013
Long-term restorative effects of bromocriptine on operant responding in the 6-hydroxydopamine-lesioned ratEllen M Murphy, Mariah J Lelos, Michael J O'Neill, et al.
Journal of Parkinson'S Disease|August 13, 2013
Amphetamine-induced dyskinesia in the transplanted hemi-Parkinsonian mouseGaynor A Smith, Andreas Heuer, Alexander Klein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2021
Spontaneous Graft-Induced Dyskinesias Are Independent of 5-HT Neurons and Levodopa Priming in a Model of Parkinson's DiseaseEmma L Lane, David J Harrison, Elena Ramos-Varas, et al.
Journal of Parkinson'S Disease|April 25, 2022
Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced DyskinesiaOsama F Elabi, Rachel Pass, Irene Sormonta, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Experimental Neurology|December 17, 2013
The effect of additional noradrenergic and serotonergic depletion on a lateralised choice reaction time task in rats with nigral 6-OHDA lesionsHanna S Lindgren, Merve Demirbugen, Filip Bergqvist, et al.
Brain Research Bulletin|December 17, 2008
Genetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA modelChristelle Monville, Eduardo M Torres, Vladimir Pekarik, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 8, 2021
Factors affecting the choice of first-line therapy in Parkinson's disease patients in Wales: A population-based studyKhalid Orayj, Ashley Akbari, Arron Lacey, et al.
Behavioural Brain Research|December 8, 2011
Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sitesAndreas Heuer, Gaynor A Smith, Mariah J Lelos, et al.
Brain, Behavior, and Immunity|November 20, 2016
Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's diseaseLudivine S Breger, Korbinian Kienle, Gaynor A Smith, et al.
Scientific Reports|October 17, 2023
Impaired cognitive and motor function are coincident with L-DOPA-induced dyskinesia in a model of Parkinson's diseaseMariah J Lelos, Ellen M Murphy, Hanna S Lindgren, et al.
Neuroreport|October 23, 2013
Long-term restorative effects of bromocriptine on operant responding in the 6-hydroxydopamine-lesioned ratEllen M Murphy, Mariah J Lelos, Michael J O'Neill, et al.
Journal of Parkinson'S Disease|August 13, 2013
Amphetamine-induced dyskinesia in the transplanted hemi-Parkinsonian mouseGaynor A Smith, Andreas Heuer, Alexander Klein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2021
Spontaneous Graft-Induced Dyskinesias Are Independent of 5-HT Neurons and Levodopa Priming in a Model of Parkinson's DiseaseEmma L Lane, David J Harrison, Elena Ramos-Varas, et al.
Journal of Parkinson'S Disease|April 25, 2022
Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced DyskinesiaOsama F Elabi, Rachel Pass, Irene Sormonta, et al.
Pageof 4